BioXcel Therapeutics Inc (BTAI)
2.085
-0.22
(-9.54%)
USD |
NASDAQ |
May 10, 16:00
2.13
+0.04
(+2.16%)
After-Hours: 20:00
BioXcel Therapeutics Cash from Operations (TTM): -155.01M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -155.01M |
| September 30, 2023 | -166.78M |
| June 30, 2023 | -160.38M |
| March 31, 2023 | -155.28M |
| December 31, 2022 | -135.34M |
| September 30, 2022 | -116.63M |
| June 30, 2022 | -105.65M |
| March 31, 2022 | -94.93M |
| December 31, 2021 | -82.15M |
| September 30, 2021 | -82.49M |
| June 30, 2021 | -81.40M |
| March 31, 2021 | -73.83M |
| December 31, 2020 | -66.35M |
| Date | Value |
|---|---|
| September 30, 2020 | -54.00M |
| June 30, 2020 | -42.38M |
| March 31, 2020 | -33.59M |
| December 31, 2019 | -27.10M |
| September 30, 2019 | -23.52M |
| June 30, 2019 | -19.22M |
| March 31, 2019 | -18.17M |
| December 31, 2018 | -13.51M |
| September 30, 2018 | -10.27M |
| June 30, 2018 | -7.402M |
| March 31, 2018 | -2.777M |
| December 31, 2017 | -2.196M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-166.78M
Minimum
Sep 2023
-19.22M
Maximum
Jun 2019
-88.21M
Average
-82.15M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Synlogic Inc | -51.61M |
| Cormedix Inc | -38.41M |
| Bristol-Myers Squibb Co | 13.72B |
| Verastem Inc | -86.46M |
| Ocular Therapeutix Inc | -70.23M |